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2-AW-01-1 Pharmacological approach
targeting ER stress for the treatment
Toru Hosoi, Koichiro Ozawa
Dept. Pharmacotherapy., Grad. Sch. of Biomed. and Health Sci., Hiroshima Univ.
Various stress signals, which causes accumulation of un-
folded protein in the endoplasmic reticulum (ER) activate un-
folded protein responses (UPR). There are emerging evi-
dence to suggest that ER stress would be involved in patho-
genesis of diseases such as neurodegenerative diseases, diabe-
tes, and obesity. Therefore, amelioration of unfolded protein
accumulation in the ER would be one of the useful strategies
for the treatments. In the present workshop, we would like to
show one of the candidate compounds, which can ameliorate
ER stress. The compound, flurbiprofen, was shown to reduce
protein aggregation in the in vitro system. Furthermore,
flurbiprofen reduced ER stress induced UPR. Finally, flur-
biprofen ameliorated obesity model in mice, one of the patho-
logical model of ER stress related diseases. Therefore, it
would be possible to treat ER stress related diseases by ame-
liorating unfolded protein accumulation by the chemical ap-
proach.
2-AW-01-3 Transgenic mouse models for
monitoring of ER stress
Takao Iwawaki
ERSC, Gunma Univ.
In the last 10 years, many scientists reported the association
between ER stress and various diseases. At present mammal-
ian ER stress has have received attention as an important
theme. In mammal, it is known that ER stress response is
mainly induced by three independent pathways and that each
pathway is tightly regulated and ER stress specifically acti-
vated. In this workshop, I would like introduce fluorescent
and luminescent reporter genes that are activated by molecu-
lar mechanism for mammalian ER stress response. 1) ERAI
system ; this is built on function of IRE1 that induces XBP1
splicing during ER stress. ERAI gene consists of reporter
and XBP1 that includes intron (26nt), and indicates the re-
porter activity in IRE1 dependent manner. We succeed in de-
tecting ER stress specific signals from living ERAI cells and
ERAI mice to date. 2) UMAI system ; this is built on function
of PERK that activates ATF4 translation via eIF2alpha dur-
ing ER stress. UMAI gene consists of reporter and ATF4 that
includes upstream ORF and authentic ORF, and indicates the
reporter activity in PERK dependent manner. By using
ERAI and UMAI systems we will be able to detect ER stress
in vivo less invasively and to efficiently conduct a screening
of drug for ER stress associated diseases in the future.S72-AW-01-2 The role of the membrane
bound transcription factorATF6 in
endoplasmic reticulum homeostasis
Tetsuya Okada
Dept. Biophys., Grad. Sch. of Sci., Kyoto Univ.
The endoplasmic reticulum (ER) responds to increasing de-
mand of protein folding capacity during embryonic develop-
ment, cell differentiation, or several pathological situations
by activating the unfolded protein response (UPR). ATF6,
one of the three principal signal transducers of the UPR, is a
transcription factor constitutively synthesized as a trans-
membrane protein in the ER. Upon ER stress, ATF6 relo-
cates to the Golgi apparatus to be cleaved, which in turn re-
leases its cytosolic fragment possessing transcriptional acti-
vation activity, resulting in the induction of ER chaperones
and protein degradation components. ATF6 deficiet mice
and medaka fish show higher sensitivity to ER stress and em-
bryonic lethality, indicating the conserved importance of
ATF6 signaling in managing physiological ER stress. Fur-
thermore, accumulating reports suggest that decreased ATF
6 activity is related to several diseases. Here, I will summa-
rize our current knowledge of ATF6 signaling as well as tips
for biochemical analysis of ATF6 activation. I will also de-
scribe transgenic medaka fish carrying GFP gene as a useful
tool for visualizing ER stress and ATF6 activation in living
organisms.
2-AW-01-4 The protein degradation
system in the endoplasmic reticulum
and diseases
Masayuki Kaneko
Dept. Biochem., Inst. Biomed.＆ Health Sci, Hiroshima Univ.
The endoplasmic reticulum (ER) is an organelle involved in
the maturation of membrane and secretory proteins. When
ER functions are perturbed, unfolded proteins accumulate in
the ER. This situation is termed ER stress. A large number
of ER stress related diseases and conditions, including
neurodegenerative diseases, have been reported. ER associ-
ated degradation (ERAD) is one of the ubiquitin proteasome
system (UPS) in which unfolded proteins accumulated in the
ER are selectively transported to the cytosol for degradation
by the UPS. We cloned a novel ubiquitin ligase HRD1, which
is involved in ERAD. We demonstrated that HRD1 is ex-
pressed in response to ER stress and protects against ER
stress induced apoptosis. Furthermore, we discovered the in-
volvement of HRD1 in Alzheimer’s disease. We have identi-
fied human 37 ubiquitin ligases with transmembrane domain
as HRD1, which are potentially involved in ERAD. However,
these 37 ubiquitin ligases with transmembrane domain re-
main unknown whether they are involved in unfolded protein
degradation as components of the ERAD machinery or in un-
expected protein trafficking and signal transduction. There-
fore, our goal is to elucidate novel mechanisms for the trans-
membrane ubiquitin ligases.1
3-AW-01-1 Systems pharmacology using
knockout animal models
Yuhei Nishimura 1,2,3,4,5, Reiko Kawase 1,
Toshio Tanaka 1,2,3,4,5
1Dept. Pharmacogenomics. Mie Univ. Grad. Sch. Med., 2Dept. Systems
Pharmacol., Mie Univ. Grad. Sch. Med., 3Mie Univ. Medical Zebrafish Research C,
4Dept. Bioinfo., Mie Univ. Life Science Research C., 5Dept. Omics Med., Mie Univ.
Ind. Tech. Innov. Inst.
The rapid growth in the genome editing technology has
made it easy to generate knockout animal models. We have
developed various knockout zebrafish models of human dis-
eases and used them for systems pharmacology. In this work-
shop, we would like to introduce orexin knockout zebrafish
using TALEN and a behavioral assay for analyzing the sleep
wake states of zebrafish. The assay can be performed using
48 well plates, making it suitable for screening and charac-
terize novel therapeutic compounds to treat sleep wake dis-
turbances.
2-W-01-1 Production and application of
adenoviral vectors, adeno associated
viral vectors and lentiviral vectors
Kazuki Nagayasu 1,2
1Drug Innov. Ctr., Grad. Sch. Pharm. Sci., Osaka Univ., 2Dept. Mol. Pharmacol.,
Grad. Sch. Pharm. Sci., Kyoto Univ.
Viral vectors such as adenoviral vectors (AVV), adeno asso-
ciated viral vectors (AAV) and lentiviral vectors (LVV) pro-
vide an efficient and versatile system for gene expression
both in vitro and in vivo . Due to wide tropism of viral vec-
tors for a variety of mammalian cells including neurons, viral
vectors in conjunction with the optogenetic and pharmacoge-
netic tools are playing more and more important role in the
analysis and dissection of neural circuits, which are the basis
of the brain functions. Viral vectors themselves, however,
have drawn less attention than the genetic tools. Here we in-
troduce the production and application of these viral vectors
and to summarize the advantages and current limitations of
them.S73-AW-02-1 Basics and recent results of
autophagy mechanisms
Nobuo Noda
Lab. Mol. Struct., Inst. Microbial Chem.
Autophagy is an intracellular degradation system that de-
grades various cytoplasmic materials such as proteins, lipids,
nucleic acids and organelles. Autophagy contributes to cell
homeostasis through selective degradation of specific targets
in addition to the role of non selective degradation upon star-
vation. Autophagy involves complicated membrane dynam-
ics, which are accomplished by the concerted actions of vari-
ous autophagy related (Atg) proteins. In this workshop, I
summarize the basic mechanisms of autophagy and the mo-
lecular roles of each Atg factor, and then present recent evi-
dence of autophagy mechanisms that include the molecular
mechanisms of autophagy initiation by starvation and selec-
tive cargo recognition during receptor mediated selective
autophagy.
2-W-01-2 Dissection of olfactory
neuronal circuits using modified rabies
virus
Koshi Murata
Div. Brain Str. Func., Fac. Med., Univ. Fukui
To understand how the brain works, it is essential to identify
synaptic connectivity of neurons. Various neuronal subtypes
are intermingled and involved in distinct subcircuits. There-
fore, tracing methods that reveals neuronal connectivity in a
cell type specific manner are required. Retrograde tracers
are used to label input neurons onto a region of interest. An
ideal retrograde tracer is potent to target a single or limited
number of post synaptic cells in a specific neuronal subtype.
However, conventional retrograde tracers have some limita-
tions, because they cannot distinguish whether retrogradely
labeled neurons have synaptic inputs or passing axon fibers
in a region of interest. In addition, conventional retrograde
tracers cannot target specific neuronal subtypes of postsyn-
aptic cells. Rabies virus is a natural retrograde tracer which
can spread from postsynaptic cells to presynaptic cells. Re-
cently, Wickersham et al. reported modified rabies virus that
crosses only one step of synapses from a single postsynaptic
cell, whose neuronal subtypes can be genetically targeted. In
this talk, we review the retrograde transsynaptic tracing
method using the modified rabies virus, and introduce our re-
cent application addressing olfactory neuronal circuits of
mice.2
2-W-01-3 Usefulness of DREADD
technology combined with adeno
associated virus vector in behavioral
pharmacology
Hiroyuki Mizoguchi 1, Akihiro Yamanaka 2,
Kiyofumi Yamada 3
1 Res. Ctr. Next Generation Drug Dev., Res. Inst. Environmental Med., Nagoya
Univ., 2Dep. Neuroscience II, Res. Inst. Environmental Med., Nagoya Univ., 3Dep.
Neuropsychopharmacol. Hosp. Pharm., Nagoya Univ. Grad. Sch. Med.
One of the most challenging goals of modern neuroscience
and pharmacology is to define the molecular and cellular ba-
sis for higher brain function such as learning and memory
and, ultimately, for neuropsychiatric disorders. One ap-
proach to this fundamental subject is to manipulate the gene
expression using viral vectors to transfect specific genes into
specific brain cell populations. Recently, we have demon-
strated that insular cortex plays a role in decision making in
healthy and methamphetamine treated rats by using de-
signer receptors exclusively activated by designer drug
(DREADDs) technology, a powerful tool to control the cellu-
lar activity. The mCherry tagged mutant human M3 mus-
carinic receptor (hM3Dq) or mutant human M4 muscarinic
receptor (hM4Di) transgene was expressed under the control
of the CMV promoter using adeno associated virus (AAV)
vectors. Through this gene expression, we were successful in
manipulating decision making for arm choice behaviors in
rats. In this workshop, we will talk about usefulness of AAV
vectors for manipulating behavior and the function in neural
systems.
2-W-02-2 Discovery of a new cytosolic
phospholipaseA2 inhibitor as a
promising drug candidate for treatment
of respiratory diseases
Maki Terakawa, Toshiyuki Tomoo,
Yasuhiro Hayashi, Kazuhiro Nagahira
ASUBIO PHARMACO., LTD.
Group IVA cytosolic phospholipase A2 (cPLA2α) is a key en-
zyme for the stimuli induced production of inflammatory
lipid mediators and thought to contribute to the pathogenesis
of various inflammatory diseases. Based on the crystal struc-
ture of the screening hit compound from our compound li-
brary, we originally designed new indole based small mo-
lecular cPLA2α inhibitors. We optimized our new inhibitors
which inhibited arachidonic acid release in enzyme assay, ei-
cosanoid production in cell based assay, and displayed good
PK profile.ASB14780, one of the selected inhibitors with IC50
for human cPLA2α of 0.014μM, showed good oral efficacy on
late asthmatic response and airway hyperresponsiveness at
doses of 3 mg/kg and higher in asthma model using guinea
pig. In addition, ASB14780 treatment significantly inhibited
the increases of specific airway resistance, functional resid-
ual capacity and residual volume at doses of 3 mg/kg and
higher in 4 weeks cigarette smoke exposure model using
guinea pigs. These results support a potential therapeutic
role of cPLA2α inhibitors for the treatment of respiratory
diseases, such as asthma and COPD.S72-W-02-1 Drug discovery and
development for COPD by drug
repositioning strategy
Ken ichiro Tanaka
Dept. Drug. Dis.＆ Dev., Fac. Pharm., Keio Univ.
The clinical treatment of chronic obstructive pulmonary dis-
ease (COPD) requires not only an improvement of airflow by
bronchodilation but also the suppression of emphysema by
controlling inflammation. Here we screen a compound li-
brary consisting of clinically used drugs for their ability to
prevent elastase induced airspace enlargement in mice. We
show that intratracheal administration of mepenzolate bro-
mide (mepenzolate), a muscarinic antagonist used to treat
gastrointestinal disorders, decreases the severity of elastase
induced pulmonary damage. While mepenzolate shows bron-
chodilatory activity, most other muscarinic antagonists do
not improve elastase induced pulmonary disorders. Further-
more, the intratracheal route of mepenzolate administration,
but not other routes, resulted in protective effects against
elastase induced pulmonary damage and bronchodilation at a
much lower dose than that which affected defecation and
heart rate. These results suggest that pulmonary route of
mepenzolate administration may be effective to treat COPD
patients due to its anti inflammatory and bronchodilatory ac-
tivities.
2-W-02-3 The investigation for drugs to
suppress Group2 innate lymphoid cell
(ILC2) in fungus induced asthma
Koichi Fukunaga
Dept. Pulmonary, Keio Univ. Sch. Med.
Group2 innate lymphoid cell (ILC2) produces a significant
amount of Type 2 cytokines, IL 5 and IL 13 in response to
IL 33. ILC2 may play an important role in human asthma. On
the other hands, Alternaria, one of the asthma related envi-
ronmental fungus, induces airway eosinophic inflammation in
mice because it contains a cysteine protease that potently in-
duces airway epithelial cells to produce IL 33. We demon-
strated whether some existing drugs have a potential effect
on ILC2 in Alternaria induced asthma murine model using a
new strategy for drug discovery & development (DR).3
2-W-02-4 Ibudilast as a drug
repositioning candidate for controlling
hyperproduction of airway mucin
Yoichiro Isohama
Lab. Appl. Pharmacol., Fac. Pharmac. Sci., Tokyo Univ. Sci.
Overproduction of mucin is a common pathological feature in
asthma and chronic obstructive pulmonary disease (COPD).
Although it is associated with disease progression, effective
therapies that directly target mucin overproduction and hy-
persecretion are lacking. It is, therefore, valuable to find new
possible activity of controlling mucus hyperproductin. In the
present study, we examined effects of varuius drugs on MUC
5AC secretion and expression in NCI H292 bronchial epithe-
lial cells. We have found that budilast, a phosphodiesterase 4
(PDE4) inhibitor considerably inhibited TGF α induced
MUC5AC secretion to the media. Ibudilast also inhibited
MUC5AC mRNA expression, whereas it did not affect mRNA
stability, suggesting this drug inhibits MUC5AC gene tran-
scription. In contrast, other PDE inhibitors, such as theophil-
lin, dipyridamole and milrinone, did not affect MUC5AC se-
cretion. Furthermore, the inhibition by ibudilast on MUC5AC
secretion was insensitive to H 89, and dibutyl cAMP did not
inhibit MUC5AC expression. These data indicated that ibudi-
last can inhibit MUC5AC expression and this effect may be
through new mechanism which is different from PDE inhibi-
tion.
3-W-01-2 Challenges of PMDA for
utilizing electronic medical records for
assessment of drug safety
Yoshiaki Uyama
Pharmaceuticals and Medical Devices Agency
Electronic medical record (EMR) has been the center of at-
tention as a valuable source for drug safety assessment based
on pharmacoepidemiological approaches. PMDA launched
MIHARI project in FY2009 in order to establish an internal
framework for utilizing EMR on safety assessment of drugs.
Since FY2014 its operation has been implemented on a real
scenario for regulatory decision making. For more real time
assessment with detailed information, PMDA has initiated
the new project called as MID NET to establish large EMR
database in Japanese patients since FY2011. Currently, the
MID NET includes HIS, claim and DPC data from 10 medi-
cal institutions of 23 hospitals in Japan and is designed to en-
able pharmacoepidemiological analysis integrating data from
multiple institutions in a real time manner. In this presenta-
tion, PMDA’s activities regarding pharmacoepidemiological
safety assessment of drugs are described and future chal-
lenges on utilization of EMR for drug evaluation will be dis-
cussed.S73-W-01-1 Medical Big Data and
Pharmacology for Healthcare
Yuji Yoshiyama
Div. Clinical Pharmacy, Kitasato Univ., Sch. Pharmacy
In this symposium, we will discuss medical big data and phar-
macology. The profession is moving toward a model that at-
tempts to integrate patient centered care with drug distribu-
tion services. The term pharmaceutical care is used to de-
scribe the broad based, patient focused responsibilities of
pharmacists. Pharmaceutical care is a patient centered, out-
comes oriented pharmacy practice that requires the pharma-
cist to work in concert with the patient and the patient’s
other health care providers to promote health, to prevent dis-
ease, and to assess, monitor, initiate, and modify medication
use. Pharmacists are crucial in the selection of safe and effec-
tive prescription and nonprescription products for patients.
Pharmaceutical care is one of very important roles. Recently
patient and pharmacy claims data (receipts created for health
insurance payment systems) provide for healthcare. The opti-
mal solution based on analysis of claims information is pro-
vided for the use in wide ranging areas as well as in medical
institution and research institutions. The objective of this
symposium is that understand the necessity of a pharma-
cological knowledge in the provision of healthcare and big
data.
3-W-01-3 RealWorld Data, the growth
and value
Shinya Kimura
JMDC
In recent years, the healthcare/medical big data (Real World
Data : RWD) like claim databases have shown a remarkable
growth. RWD is used for observational studies such as de-
scriptive statistics, cohort studies, drug safety, quality of
clinical practices, outcomes study, health economics and
HTA. Patient’s consultation behavior, diagnoses, clinical pro-
cedures and drug usages can be observed by using RWD.
One patient has usually more than one disease, in other
words, understanding of co morbidity in addition to compli-
cations gives a new insight for a real world of drug usage.
Moreover, RWD is a longitudinal data that can understand a
deterioration rate of symptoms or recurrence rate.
Understanding recent situation of RWD and its potential
would be value for the future.4
